Author:
Pathak Bhakti R.,Breed Ananya A.,Apte Snehal,Acharya Kshitish,Mahale Smita D.
Funder
Department of Atomic Energy (DAE), BRNS, Government of India (IN)
Indian Council of Medical Research (IN)
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine
Reference34 articles.
1. Obort AS, Ajadi MB, Akinloye O (2013) Prostate-specific antigen: any successor in sight? Rev Urol 15:97–107
2. Kosari F, Asmann YW, Cheville JC, Vasmatzis G (2002) Cysteine-rich secretory protein-3: a potential biomarker for prostate cancer. Cancer Epidemiol Biomarkers Prev 11:1419–1426
3. Bjartell AS, Al-Ahmadie H, Serio AM, Eastham JA, Eggener SE, Fine SW et al (2007) Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy. Clin Cancer Res 13:4130–4138
4. Dahlman A, Edsjö A, Halldén C, Persson JL, Fine SW, Lilja H et al (2010) Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3. Prostate Cancer Prostatic Dis 13:369–375. doi: 10.1038/pcan.2010.25
5. Grupp K, Kohl S, Sirma H, Simon R, Steurer S, Becker A et al (2013) Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence. Mod Pathol 26:733–742. doi: 10.1038/modpathol.2012.206
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献